|Hospital Inpatient Mortality|
RW Dubois, WH Rogers, JH Moxley, D Draper, RH Brook
RAND Corporation, 1991
|Best Practices: Improving Patient Outcomes and Costs in an ACO Through Comprehensive Medication Therapy Management|
A Brummel, A Lustig, K Westrich, MA Evans, GS Plank, J Penso, ...
J Manag Care Pharm 20 (12), 1152-58, 2014
|Surveillance after polypectomy and after resection of colorectal cancer|
C Arditi, JJ Gonvers, B Burnand, G Minoli, D Oertli, F Lacaine, RW Dubois, ...
Endoscopy 41 (3), 209-217, 2009
|Private sector risk-sharing agreements in the United States: trends, barriers, and prospects.|
LP Garrison, JJ Carlson, PS Bajaj, A Towse, PJ Neumann, SD Sullivan, ...
The American journal of managed care 21 (9), 632-640, 2015
|Cost-effectiveness thresholds in the USA: are they coming? Are they already here?|
Journal of comparative effectiveness research 5 (1), 9-12, 2016
The New England journal of medicine 330 (6), 433; author reply 433-4, 1994
|Are ACOs ready to be accountable for medication use|
RW Dubois, M Feldman, A Lustig, G Kotzbauer, J Penso, SD Pope, ...
J Manag Care Pharm 20 (1), 17-21, 2014
|Real-world impact of comparative effectiveness research findings on clinical practice.|
TB Gibson, ED Ehrlich, J Graff, R Dubois, AM Farr, M Chernew, ...
The American journal of managed care 20 (6), e208-20, 2013
|Adverse effects and reasons for switch reported by patients on antihypertensive medications|
K Chen, D Glass, CF Chiou, C Plauschinat, F Frech, A Harper, R Dubois
American Journal of Hypertension 17 (5), S102, 2004
|Best Practices: An Electronic Drug Alert Program to Improve Safety in an Accountable Care Environment|
S Griesbach, A Lustig, L Malsin, B Carley, KD Westrich, RW Dubois
Journal of managed care & specialty pharmacy 21 (4), 330-336, 2015
|When is evidence sufficient for decision-making? A framework for understanding the pace of evidence adoption|
RW Dubois, M Lauer, E Perfetto
Journal of comparative effectiveness research 2 (4), 383-391, 2013
|Transparency in Evidence Evaluation And Formulary Decision-Making: From Conceptual Development to Real-World Implementation|
BB Dean, KJ Ko, JS Graff, AR Localio, R Wade, RW Dubois
Pharmacy and Therapeutics 38 (8), 465, 2013
|The development of indications for the preoperative use of recombinant erythropoietin|
RW Dubois, D Lim, P Hebert, M Sherwood, GH Growe, JF Hardy, RE Park, ...
Canadian journal of surgery 41 (5), 351, 1998
|From Conceptual Development to Real-World Implementation|
BB Dean, RW Dubois
|Role of pharmaceuticals in value-based healthcare: a framework for success.|
RW Dubois, M Feldman, J Martin, J Sanderson-Austin, KD Westrich
The American journal of managed care 18 (7), 1 p following e244, 2012
|Looking at CER from the pharmaceutical industry perspective|
Journal of Managed Care Pharmacy 18 (4), S9, 2012
|Does type of bolus insulin matter in the hospital? Retrospective cohort analysis of outcomes between patients receiving analogue versus human insulin|
KJ Ko, V Tomor, BH Nathanson, JR Bouchard, M Aagren, RW Dubois
Clinical therapeutics 32 (11), 1954-1966, 2010
|Solutions for filling gaps in accountable care measure sets.|
T Valuck, D Dugan, RW Dubois, K Westrich, J Penso, M McClellan
The American journal of managed care 21 (10), 723-728, 2015
|The value of specialty pharmaceuticals-a systematic review.|
M Zalesak, JS Greenbaum, JT Cohen, F Kokkotos, A Lustig, PJ Neumann, ...
The American journal of managed care 20 (6), 461-472, 2014
|Does the presence of hypertension affect cardiovascular benefits of statin therapy? Results from a meta-regression analysis of 69,984 patients|
FH Messerli, L Pinto, S Tang, KM Thakker, JC Cappelleri, T Sichrovsky, ...
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 47 (4), 371A-371A, 2006